ES2573462T3 - Polipéptidos de PH20 soluble extendida y usos de los mismos - Google Patents

Polipéptidos de PH20 soluble extendida y usos de los mismos Download PDF

Info

Publication number
ES2573462T3
ES2573462T3 ES09804345.8T ES09804345T ES2573462T3 ES 2573462 T3 ES2573462 T3 ES 2573462T3 ES 09804345 T ES09804345 T ES 09804345T ES 2573462 T3 ES2573462 T3 ES 2573462T3
Authority
ES
Spain
Prior art keywords
polypeptides
extended soluble
soluble
extended
hyaluronidase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES09804345.8T
Other languages
English (en)
Inventor
Ge Wei
Krishnasamy Panneerselvam
Gregory I. Frost
Louis Bookbinder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Halozyme Inc
Original Assignee
Halozyme Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Halozyme Inc filed Critical Halozyme Inc
Priority claimed from PCT/US2009/006501 external-priority patent/WO2010077297A1/en
Application granted granted Critical
Publication of ES2573462T3 publication Critical patent/ES2573462T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Hialuronidasa PH20 truncada que consiste en la secuencia de residuos de aminoácido 36-469, 36-470 ó 36-471 de SEQ ID NO: 107.
ES09804345.8T 2008-12-09 2009-12-09 Polipéptidos de PH20 soluble extendida y usos de los mismos Active ES2573462T3 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US28124P 1996-10-15
US20138408P 2008-12-09 2008-12-09
US201384P 2008-12-09
US2812409P 2009-11-13 2009-11-13
PCT/US2009/006501 WO2010077297A1 (en) 2008-12-09 2009-12-09 Extended soluble ph20 polypeptides and uses thereof

Publications (1)

Publication Number Publication Date
ES2573462T3 true ES2573462T3 (es) 2016-06-08

Family

ID=56100055

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09804345.8T Active ES2573462T3 (es) 2008-12-09 2009-12-09 Polipéptidos de PH20 soluble extendida y usos de los mismos

Country Status (1)

Country Link
ES (1) ES2573462T3 (es)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4194551A4 (en) * 2020-08-07 2024-08-28 Alteogen, Inc. PROCESS FOR PRODUCING RECOMBINANT HYALURONIDASE
US12371683B2 (en) 2018-07-25 2025-07-29 Alteogen Inc. Hyaluronidase variants and pharmaceutical composition comprising the same
US12570766B2 (en) 2019-03-25 2026-03-10 Alteogen Inc. Pharmaceutical composition for subcutaneous administration containing human hyaluronidase PH20 variant and drug

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12371683B2 (en) 2018-07-25 2025-07-29 Alteogen Inc. Hyaluronidase variants and pharmaceutical composition comprising the same
US12570766B2 (en) 2019-03-25 2026-03-10 Alteogen Inc. Pharmaceutical composition for subcutaneous administration containing human hyaluronidase PH20 variant and drug
EP4194551A4 (en) * 2020-08-07 2024-08-28 Alteogen, Inc. PROCESS FOR PRODUCING RECOMBINANT HYALURONIDASE

Similar Documents

Publication Publication Date Title
MX2012002272A (es) Dominios cataliticos de lisil oxidasa y loxl2.
BR112012017345A2 (pt) "composições e métodos de pgl para a produção aumentada de isopreno e outros produtos com 6-fosfogliconolactonase (pgl)"
BR112012014082A2 (pt) composições e métodos que compreendem variantes de protease
DK2158319T3 (da) Knoglemålrettet alkalisk fosfatase, kits og fremgangsmåder til anvendelse deraf
WO2009117439A3 (en) Combined chemical and genetic approaches for generation of induced pluripotent stem cells
TN2011000382A1 (en) Indole derivatives as crth2 receptor antagonists
UA106586C2 (uk) Анти-cd79b антитіла, і імунокон'югати та способи їх застосування
MX2009005655A (es) Composiciones y usos de un polipeptido alfa-amilasa del bacilo de la especie 195.
EA201170878A1 (ru) Полипептиды с ксиланазной активностью
GT201200189A (es) Antagonistas de pcsk9
IN2012DN00801A (es)
MX2009004435A (es) Tinturas dispersas, su preparacion y su uso.
MX347545B (es) Polipeptidos con actividad xilanasa.
BRPI1015043A2 (pt) derivados de diazahomoadamantano e métodos de uso dos mesmos
MY150226A (en) Novel h5 proteins, nucleic acid molecules and vectors encoding for those, and medicinal use
UA100127C2 (ru) Пептид cdh3 и лекарственное средство, содержащее его
MX2009013515A (es) Derivados de 7-alquinil-1,8-naftiridonas, su preparacion y su aplicacion en terapeutica.
MX371403B (es) Moleculas de andamiaje a base de fibronectina estabilizada.
IN2012DN00852A (es)
CO6450607A2 (es) Antagonistas del receptor tipo toll 3
TW200940707A (en) Detergent composition
UY29857A1 (es) Derivados de la 4-amino-quinazolina, su preparación y su aplicación en terapéutica.
ES2573462T3 (es) Polipéptidos de PH20 soluble extendida y usos de los mismos
WO2009047634A3 (en) Aqueous formulations of acetaminophen for injection
ATE486128T1 (de) Zusammensetzungen und verfahren zur erhöhung der produktion rekombinanter gamma-carboxylierter proteine